A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With
Advanced Solid Tumors
Is the drug BMS-813160 safe, tolerable and effective when given alone or in combination
with other chemotherapy drugs in patients with metastatic colorectal and pancreatic
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This study will evaluate the safety profile, tolerability, and effectiveness of the
drug BMS-813160 in patients with metastatic colorectal and pancreatic cancers.
Study Reference #: IGIM18001
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Nicholas Gerbino
Phone: (585) 273-2605
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search